Comment on the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project by McSorley, Stephen T. et al.
  
 
 
 
 
McSorley, S. T., Talwar, D. and McMillan, D. C. (2018) Comment on the Biomarkers 
Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. 
American Journal of Clinical Nutrition, 108(1), pp. 204-205. 
 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/165604/  
      
 
 
 
 
 
 
Deposited on: 13 August 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
1 
 
Letter to Editor: 1 
Comment on the Biomarkers Reflecting Inflammation and Nutritional Determinants of 2 
Anemia (BRINDA) project 3 
 4 
Stephen T McSorley1, Dinesh Talwar2, Donald C McMillan1  5 
1. Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow, UK 6 
2. The Scottish Trace Elements and Micronutrients Reference Laboratory, Department 7 
of Clinical Biochemistry, Glasgow Royal Infirmary, Glasgow G4 0SF. 8 
 9 
Corresponding author: 10 
Mr Stephen McSorley, Clinical Research Fellow 11 
Level 2, New Lister Building, Glasgow Royal Infirmary, Glasgow, UK 12 
Postcode: G31 2ER 13 
Tel: 0141 211 8675 14 
Email: s.mcsorley@doctors.org.uk 15 
 16 
Conflict of interest/Disclosure: none 17 
 18 
 19 
 20 
2 
 
Dear Sir,  21 
We read with interest the recent series of publications of the Biomarkers Reflecting 22 
Inflammation and Nutritional Determinants of Anemia (BRINDA) project (1-4).  These 23 
publications highlight the perturbation of plasma measures of iron status and anemia as part 24 
of the systemic inflammatory response in a variety of cohorts including pre-school children 25 
and women of reproductive age (4).  This perturbation has long been recognised (5-6).  26 
However, it is only recently that the magnitude of the effect has been well described in large 27 
numbers of patient observations (7).  There have been two main approaches to the 28 
confounding effect of the systemic inflammatory response on the measurement of iron status.  29 
The first is to develop other measurements of iron status that are not affected by systemic 30 
inflammation.  The second is to adjust measurement of iron status and anemia using measures 31 
of systemic inflammation (8).   32 
In the BRINDA publications this second approach has been carried out using C-33 
reactive protein (CRP), and α-1-acid glycoprotein (AGP), two positive acute phase proteins 34 
of varying half-life.  They reported significant differences in the prevalence of depleted iron 35 
stores based on serum ferritin criteria (1).  When serum ferritin was examined in women of 36 
reproductive age there was a significant difference in the proportion of patients meeting 37 
criteria for iron deficiency (<15 μg/L) in the lowest and highest decile of both CRP (29% and 38 
6% respectively) and AGP (26% and 8% respectively).  In addition, when women of 39 
reproductive age were grouped by phase of inflammation using the combination of CRP and 40 
AGP, there was as significant difference in the mean lowest (34.9 μg/L, 95% CI 25.7-47.4, in 41 
“reference” group [CRP ≤5mg/L and AGP  ≤1g/L]) and highest ferritin concentration (59.2 42 
μg/L, 95% CI 48.5-72.2 in “early convalescence” group [CRP >5mg/L and AGP >1g/L]).  43 
Furthermore, the authors show that measures of iron status are altered below currently 44 
clinically relevant threshold values for both CRP and AGP and so propose that the use of a 45 
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regression based correction factor should provide a more accurate assessment of true iron 46 
status in the context of systemic inflammation (1).  However, AGP is not routinely available 47 
as a measure of systemic inflammation in the clinical setting.    In the BRINDA project paper 48 
the authors propose the continued and expanded use of AGP as a measure of the phase and 49 
magnitude of systemic inflammation.  However, as they themselves note, “…CRP is the more 50 
routinely measured and should continue to be measured along with AGP…”, in part as it is 51 
not routinely used in clinical practice (1).  In addition, the authors also discuss in an earlier 52 
publication, the problem associated with the calculation of regression based correction factors 53 
caused by serum micronutrient concentrations that do not necessarily “move in synchrony” 54 
with the CRP and AGP defined phases of inflammation (10). 55 
Perhaps a better approach would be to use the combination of CRP and albumin, since 56 
both are independently associated with measures of iron status, and are routinely available.  57 
We recently published an observational study using such a method in a large mixed cohort of 58 
16,552 adult patients in the UK (9).  Patients were stratified by the magnitude of the systemic 59 
inflammatory response using both CRP and albumin as follows;  group 1: CRP <10mg/L and 60 
albumin >35g/L, group 2: CRP11-80mg/L and albumin 25-35mg/L, and group 3:  CRP 61 
>80mg/L and albumin <25g/L.  When serum ferritin was compared amongst the 3 groups the 62 
median concentration was 77, 173 and 445 μg/L respectively (p<0.001).  Furthermore, there 63 
was a significant difference in the proportion of patients meeting criteria for iron deficiency 64 
(<15 μg/L, 13%, 3% and 0% respectively, p=0.001) or iron excess (M>300 μg/L F>50 μg/L, 65 
21%, 38% and 75% respectively, p<0.001). When transferrin saturation was compared 66 
amongst the 3 groups there was a significant difference in the proportion of patients meeting 67 
criteria for iron deficiency (TSAT <10%, 15%, 39% and 53% respectively, p<0.001) or iron 68 
excess (TSAT M>55% F>50%, 7%, 5% and 5% respectively, p<0.001). 69 
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Given that serum albumin in combination with CRP has been shown to both stratify 70 
the magnitude of the systemic inflammatory response, is associated with common measures 71 
of iron status, and is routinely clinically available, it might be useful to explore the 72 
calculation of such proposed regression based correction factors using the combination of 73 
CRP and albumin rather than AGP.  With the significant interest in iron status in clinical 74 
practice, including the ongoing clinical trials of parenteral iron regimens in patients 75 
undergoing elective surgery deemed to be iron deficient, such an approach could have a 76 
considerable impact on the requirements for such treatments, and related therapies, including 77 
allogeneic blood transfusion. 78 
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